REPL Replimune Group Inc

Price (delayed)

$21.41

Market cap

$2.03B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.79

Enterprise value

$1.85B

?
Relative Growth: Rel. Growth: 11
Relative Strength: Rel. Strength: 99
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 6
Highlights
Replimune Group's quick ratio has increased by 33% from the previous quarter and by 10% YoY
The company's EPS rose by 19% YoY and by 11% QoQ
The company's equity has surged by 94% QoQ but it fell by 22% YoY
Replimune Group's debt has soared by 67% YoY and by 14% from the previous quarter

Key stats

What are the main financial stats of REPL

REPL stock price

How has the Replimune Group stock price performed over time
Intraday
-2.19%
1 week
-3.82%
1 month
97.15%
1 year
138.15%
YTD
120.27%
QTD
61.71%

Financial performance

How have Replimune Group's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$269.73M
Net income
-$271.03M
Gross margin
N/A
Net margin
N/A
The operating income has increased by 16% year-on-year and by 9% since the previous quarter
The net income has grown by 13% YoY and by 9% from the previous quarter

Price vs fundamentals

How does REPL's price correlate with its fundamentals

Growth

What is Replimune Group's growth rate over time

Valuation

What is Replimune Group stock price valuation
P/E
N/A
P/B
9.85
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 19% YoY and by 11% QoQ
The company's equity has surged by 94% QoQ but it fell by 22% YoY
REPL's price to book (P/B) is 76% higher than its last 4 quarters average of 5.6

Efficiency

How efficient is Replimune Group business performance
Replimune Group's return on invested capital has shrunk by 99% YoY and by 12% QoQ
REPL's ROE has shrunk by 91% YoY
Replimune Group's return on assets has decreased by 36% YoY but it has increased by 8% QoQ

Dividends

What is REPL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for REPL.

Financial health

How did Replimune Group financials performed over time
The total assets is 121% more than the total liabilities
The total assets is up by 48% from the previous quarter but it is down by 4% YoY
REPL's current ratio is up by 36% QoQ and by 13% YoY
Replimune Group's debt is 38% less than its equity
The debt to equity has surged by 114% year-on-year but it has declined by 42% since the previous quarter
The company's equity has surged by 94% QoQ but it fell by 22% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.